Adjuvant Chemotherapy Trial of TS-1 for Gastric Cancer (ACTS-GC)
Phase of Trial: Phase III
Latest Information Update: 13 May 2016
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary)
- Indications Gastric cancer
- Focus Adverse reactions; Therapeutic Use
- Acronyms ACTS-GC
- Sponsors Taiho Pharmaceutical
- 27 Jan 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 15 Oct 2010 According to a Taiho Pharmaceutical media release, the five-year follow-up results of this trial were presented at the meeting of the European Society for Medical Oncology (ESMO-2010).
- 15 Oct 2010 According to a Taiho Pharmaceutical media release, these results are expected to be reported at the 48th Annual Meeting of the Japan Society of Clinical Oncology.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History